The Xenotransplantation Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).
Learn More On The Xenotransplantation Market:
https://www.thebusinessresearchcompany.com/report/xenotransplantation-global-market-report
According to The Business Research Company’s Xenotransplantation Global Market Report 2024, The xenotransplantation market size has grown strongly in recent years. It will grow from $13.48 billion in 2023 to $14.58 billion in 2024 at a compound annual growth rate (CAGR) of 8.2%. The growth in the historic period can be attributed to growing demand for organ transplant, animal breeding, clinical trials, developments in regulatory approvals, surgical techniques.
The xenotransplantation market size is expected to see strong growth in the next few years. It will grow to $19.96 billion in 2028 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to global healthcare infrastructure, public funding, telemedicine, public perception and acceptance, use of AI. Major trends in the forecast period include personalized xenotransplantation, multi-organ transplants, integration with precision medicine, long-term monitoring solutions, use of blockchain.
The increase in demand for tissue and organ transplantation is expected to propel the xenotransplantation market. A hereditary disorder like polycystic kidney disease, cystic fibrosis, or a heart malfunction might lead to the need for an organ transplant in a large number of people. The high demand for organ transplants has led to a shortage of organs. Xenotransplantation helps deal with this shortage by using nonhuman organs instead of human organs. For instance, according to a report published in January 2022 by the Organ Procurement and Transplantation Network (OPTN), a public-private partnership that links all professionals involved in the U.S. donation and transplantation system, the number of organ transplants in the United States increased to 41,354 in 2021 from 40,000 in 2020, showing an increase of 5.9%. Therefore, the increasing demand for tissue and organ transplantation will drive the xenotransplantation market.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=8326&type=smp
The xenotransplantation market covered in this report is segmented –
1) By Products: Organ Preservation Solutions, Transplant Diagnostics, Tissue Products
2) By Treatment: Analgesic, Immunosuppressant, Other Treatments
3) By Applications: Heart, Kidney, Other Organs
4) By End-Users: Hospitals, Transplant Centers, Other End-Users
Major companies operating in the xenotransplantation market are focusing on strategic partnerships to provide reliable services to customers. A strategic partnership is an arrangement between two or more companies or organizations that helps each other or works together to achieve their respective goals. For instance, in April 2023, Karius, a US-based company and the world leader in liquid biopsy for infectious diseases, partnered with eGenesis, Inc., a US-based biotechnology company pioneering xenotransplantation, to develop human-compatible organs and cells for the treatment of organ failure. This partnership will relieve the organ shortage and accelerate the availability of safe xenotransplantation. Karius intends to utilize its platform to facilitate the identification and measurement of diseases that may be present in organ donors from pigs. The main goal of the collaboration is to build a more comprehensive testing platform for the identification of microbial cell-free DNA, which will be the foundation for surveillance and monitoring both before and after transplantation.
The xenotransplantation market report table of contents includes:
1. Executive Summary
2. Xenotransplantation Market Characteristics
3. Xenotransplantation Market Trends And Strategies
4. Xenotransplantation Market – Macro Economic Scenario
5. Global Xenotransplantation Market Size and Growth
.
.
.
26. South America Xenotransplantation Market
27. Brazil Xenotransplantation Market
28. Middle East Xenotransplantation Market
29. Africa Xenotransplantation Market
30. Xenotransplantation Market Competitive Landscape And Company Profiles
Top Major Players:
- Novartis AG
- Moderna Therapeutics
- Astellas Pharma
- United Therapeutics
- Preservation Solutions
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
